Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  MetLife    MET

METLIFE (MET)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Metlife Inc : MetLife Posts Wider 1Q Loss Than Projected On Larger Investment Losses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/27/2012 | 04:08am CEST

("MetLife Posts Wider 1Q Loss Than Projected On Smaller Tax Benefit," published at 4:59 p.m. EDT, and a correction at 5:38 p.m. misstated the reason for MetLife's wider loss. The correct version follows:)

MetLife Inc. (MET) reported a wider first-quarter loss than it projected last week as the life insurer posted larger net investment losses.

Last Friday, the biggest U.S. insurer reported preliminary results after inadvertently posting some of its financial data on its website ahead of the scheduled release.

The company posted a loss of $144 million, or 16 cents a share, widening from the $64 million it estimated last week and compared with the year-earlier profit of $877 million. It posted net investment losses of $110 million, versus the $30 million projected last week.

Operating earnings, which exclude investment gains and losses, came in at $1.37 a share, as reported last Friday. Operating revenue, which likewise strips out some investment effects, also was unchanged at $16.69 billion, up 6.9%.

The bottom-line result was driven by net derivative losses of $1.98 billion, while the year-earlier period's loss was a mere $315 million. Like its fellow insurers, MetLife uses derivatives to hedge a number of risks, including changes in interest rates and fluctuations in foreign currencies.

MetLife said earlier Thursday it is selling its reverse-mortgage business, its latest move to avoid increased regulatory scrutiny and stay focused on its core operations.

In March, it failed "stress tests" by the Federal Reserve that were aimed at gauging the capital adequacy of 19 of the biggest U.S. financial firms under a severe economic worsening.

MetLife shares closed Thursday at $36.47 and were inactive after hours. The stock is up 17% so far this year.

-By Lauren Pollock, Dow Jones Newswires; 212-416-2356; lauren.pollock@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on METLIFE
08/18 EARNINGS REVIEW AND FREE RESEARCH RE : MetLife’s Q2 Bottom-line Surged 57%..
08/18 METLIFE : Earnings Review and Free Research Report: MetLife’s Q2 Bottom-line Sur..
08/18 METLIFE : Daily Technical Summary Reports on Insurance Stocks -- Genworth Financ..
08/18 METLIFE : Launches Second Startup Engagement Program, "collab 2.0"
08/17 METLIFE : Launches Second Startup Engagement Program, “collab 2.0”
08/15 METLIFE INC : Other Events, Financial Statements and Exhibits (form 8-K)
08/15 METLIFE : Declares Third Quarter 2017 Preferred Stock Dividend
08/10 METLIFE : CFO John Hele Provides Second Quarter 2017 Financial Update Video
08/10 DELOITTE : Pivotal Voted the Ultimate Award Recipient in the 2017 WhatWorks® Awa..
08/10 METLIFE INC : Other Events, Financial Statements and Exhibits (form 8-K)
More news
News from SeekingAlpha
08/19 BRIGHTHOUSE FINANCIAL : Too Cheap To Ignore
08/14 Banks lead S&P rally
08/10 MetLife ups estimate of net investment losses related to Brighthouse spin
08/10 Blame It On The Millennials - Cramer's Mad Money (8/9/17)
08/08 Brighthouse Financial limps out of the gate after MetLife spinoff
Financials ($)
Sales 2017 65 617 M
EBIT 2017 6 007 M
Net income 2017 4 224 M
Debt 2017 -
Yield 2017 3,43%
P/E ratio 2017 13,28
P/E ratio 2018 9,22
Capi. / Sales 2017 0,76x
Capi. / Sales 2018 0,76x
Capitalization 49 976 M
Chart METLIFE
Duration : Period :
MetLife Technical Analysis Chart | MET | US59156R1086 | 4-Traders
Technical analysis trends METLIFE
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 55,2 $
Spread / Average Target 17%
EPS Revisions
Managers
NameTitle
Steven Albert Kandarian Chairman, President & Chief Executive Officer
Martin J. Lippert Executive VP-Global Technology & Operations
John C. R. Hele Chief Financial Officer & Executive Vice President
Jacki Goldstein Chief Medical Officer
Cheryl W. Grisé Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
METLIFE-12.88%49 976
AXA3.31%70 424
PRUDENTIAL11.28%60 247
PRUDENTIAL FINANCIAL INC-1.35%43 876
MANULIFE FINANCIAL CORP.1.07%38 509
AFLAC INCORPORATED14.71%31 555